SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
26.68
+0.26 (0.98%)
At close: Mar 6, 2026, 4:00 PM EST
26.94
+0.26 (0.97%)
After-hours: Mar 6, 2026, 5:04 PM EST
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $888.91 million as of March 6, 2026.
Market Cap
888.91M
Enterprise Value
978.98M
1-Year Change
n/a
Ranking
Category
Stock Price
$26.68
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $888.91M, an increase of 74.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 888.91M | 74.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 886.61M |
| Arvinas | 866.03M |
| SELLAS Life Sciences Group | 856.52M |
| BridgeBio Oncology Therapeutics | 839.88M |
| Janux Therapeutics | 837.65M |
| MannKind | 836.49M |
| Sana Biotechnology | 828.62M |
| Phathom Pharmaceuticals | 826.99M |